Stakeholder Engagement In a Comparative Effectiveness/Implementation Study to Prevent Staphylococcus Aureus Infection Recurrence: CA-MRSA Project (CAMP2). Academic Article uri icon

Overview

abstract

  • BACKGROUND: Methicillin-resistant or methicillin-sensitive Staphylococcus aureus skin and soft tissue infections pose serious clinical and public health challenges. Few protocols exist for outpatient education, decolonization and decontamination. OBJECTIVES: This trial implemented infection prevention protocols in homes via community health workers/Promotoras. METHODS: We engaged clinicians, patient stakeholders, clinical and laboratory researchers, New York-based federally qualified health centers and community hospital emergency departments. The Clinician and Patient Stakeholder Advisory Committee (CPSAC) convened in person and remotely for shared decision-making and trial oversight. RESULTS: The intervention trial consented participants with skin and soft tissue infections from Methicillin-resistant Staphylococcus aureus or methicillin-sensitive Staphylococcus aureus, completed home visits, obtained surveillance cultures from index patients and household members and sampled household environmental surfaces at baseline and three months. LESSONS LEARNED: The retention of the CPSAC during the trial demonstrated high levels of engagement. CONCLUSIONS: CPSAC was highly effective throughout design and execution by troubleshooting recruitment and home visit challenges.

publication date

  • January 1, 2022

Research

keywords

  • Community-Acquired Infections
  • Methicillin-Resistant Staphylococcus aureus
  • Soft Tissue Infections
  • Staphylococcal Infections

Identity

PubMed Central ID

  • PMC9930995

Scopus Document Identifier

  • 85127227969

Digital Object Identifier (DOI)

  • 10.1353/cpr.2022.0005

PubMed ID

  • 35342110

Additional Document Info

volume

  • 16

issue

  • 1